The assessment of a patient with persistent moderate severity asthma will most likely reveal: A) normal FEV₁between exacerbations. B) daily use of short-acting beta-2 agonist for symptom control. C) awakening from sleep no more that 3 to 4 times/month. D) normal activity is extremely limited.

Question

Quizplus · Accepted Answer

Patients with persistent moderate severity asthma typically require daily use of short-acting beta-2 agonists for symptom control.

The Assessment of a Patient with Persistent Moderate Severity Asthma